Won the Grand Prize in the International Category at “TOKYO SUTEAM DEMO DAY 2026”
FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) won the Grand Prize in the International Categor […]
Winner of the Tokyo Governor’s Award in the “Hiyocorn” Category at the “Tokyo Venture Company Championship 2025”
FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) received the Tokyo Governor’s Award—the highest […]
Winner of the Kanagawa Prefectural Governor’s Award (Grand Prize) at the “Kanagawa Business Audition 2026”
FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) was awarded the Kanagawa Prefectural Governor’s […]
Third Place at “TechGALA Grand Pitch 2026”
FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) won third place at “Grand Pitch 2026,” the main […]
FerroptoCure Received “WE AT AWARD 2025” at WE AT CHALLENGE 2025
FerroptoCure Inc. (Head Office: [City, Prefecture], Japan; CEO: Yuji Otsuki) is pleased to announce that it ha […]
Forbes Japan "100 Japanese Startups to Watch in 2026"
We are thrilled to share that FerroptoCure has been selected by Forbes JAPAN as one of the “100 Japanese Start […]
Selected to Present at the NIKKEI Drug Discovery Summit and Featured in NIKKEI Asia
We are honored to be featured in NIKKEI Asia’s coverage of the NIKKEI Drug Discovery Ecosystem Summit (June 24 […]
FerroptoCure Completes Series A Funding
~Accelerating Development of Next-Generation Cancer Therapies Through Ferroptosis Control~FerroptoCure Inc. (H […]
FerroptoCure CEO Yuji Otsuki Featured on TV Tokyo’s “Breakthrough”
FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that its CEO, Yuji Ots […]
FerroptoCure Selected for the AMED “Strengthening Program for Pharmaceutical Startup Ecosystem”
FerroptoCure Inc. (Headquarters: Tokyo, Japan; CEO: Yuji Otsuki) is pleased to announce that it has been selec […]